Clinical relevance of recipient leukocyte infusion as antitumor therapy following nonmyeloablative allogeneic hematopoietic cell transplantation
Authors:
- Megan SykesMSMegan Sykes
- 1 September 2006
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 34 (9) , 1270-1276
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissuesJournal of Experimental Medicine, 2006
- A New Strategy for Treatment of Malignant Tumor: Intra-Bone Marrow–Bone Marrow Transplantation Plus CD4− Donor Lymphocyte InfusionStem Cells, 2005
- Enhancement of Allogeneic Hematopoietic Stem Cell Engraftment and Prevention of GvHD by Intra‐Bone Marrow Bone Marrow Transplantation Plus Donor Lymphocyte InfusionStem Cells, 2004
- Graft-versus-leukemia reactions in allogeneic chimerasBlood, 2004
- Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism1Transplantation, 2003
- Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen–presenting cellsBlood, 2002
- Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimenTransplantation and Cellular Therapy, 1999
- Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationThe Lancet, 1999
- Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysNature, 1996
- An essential role for gp39, the ligand for CD40, in thymic selection.Journal of Experimental Medicine, 1995